If you’re trying to decide between dulaglutide and semaglutide for managing type 2 diabetes or losing weight, you’re facing one of the most common questions in GLP-1 therapy today. I’ve spent months researching these medications, analyzing clinical trial data, and reviewing real patient experiences.
Based on head-to-head clinical trials, semaglutide (Ozempic/Wegovy) is more effective than dulaglutide (Trulicity) for both blood sugar control and weight loss. The SUSTAIN 7 trial found semaglutide reduced HbA1c by 1.5-1.8% compared to 1.1-1.4% with dulaglutide, and produced approximately double the weight loss.
However, effectiveness isn’t the only factor that matters. Insurance coverage, side effect tolerance, and availability all play crucial roles in determining which medication works best for you.
In this comprehensive comparison, I’ll break down everything you need to know about dulaglutide vs semaglutide, including clinical trial data, real-world results, costs, and where to get prescriptions from telehealth providers in 2026.
ContentsTable of Contents
- 1Quick Comparison: Dulaglutide vs Semaglutide at a Glance→
- 2What Is Dulaglutide (Trulicity)?→
- 3FDA-Approved Uses for Dulaglutide→
- 4What Is Semaglutide (Ozempic, Wegovy, Rybelsus)?→
- 5Semaglutide Brand Names and Formulations→
- 6FDA-Approved Uses for Semaglutide→
- 7How Do Dulaglutide and Semaglutide Work?→
- 8The GLP-1 Mechanism Explained→
- 9Key Differences in Mechanism→
- 10Efficacy Comparison: SUSTAIN 7 Trial Results→
- 11SUSTAIN 7 Trial Overview→
- 12HbA1c Reduction Results→
- 13Weight Loss Comparison: Which Works Better?→
- 14SUSTAIN 7 Weight Loss Results→
- 15Why Semaglutide Wins for Weight Loss?→
- 16Side Effects: Dulaglutide vs Semaglutide→
- 17Common Side Effects Comparison→
- 18Serious Warnings (Both Medications)→
- 19Contraindications→
- 20Dosage and Administration Comparison→
- 21Dulaglutide Dosing Schedule→
- 22Semaglutide (Ozempic) Dosing Schedule→
- 23Key Dosing Differences→
- 24Cost Comparison: Trulicity vs Ozempic Pricing→
- 25Monthly Cost Without Insurance→
- 26Savings Programs Available→
- 27Insurance Coverage Considerations→
- 28Telehealth Options for 2026→
- 29Which Should You Choose?→
- 30Choose Semaglutide (Ozempic/Wegovy) If:→
- 31Choose Dulaglutide (Trulicity) If:→
- 32The Bottom Line→
- 33Frequently Asked Questions→
- 34Which is better for weight loss, semaglutide or dulaglutide?→
- 35What is better to take, Trulicity or Ozempic?→
- 36Can you lose weight on dulaglutide?→
- 37Can you switch from Trulicity to Ozempic?→
- 38What are the main differences between dulaglutide and semaglutide?→
- 39What is the new drug to replace Trulicity?→
- 40Final Verdict: Dulaglutide vs Semaglutide→
Quick Comparison: Dulaglutide vs Semaglutide at a Glance
Before diving into the details, here’s a side-by-side comparison of these two GLP-1 receptor agonists:
| Feature | Dulaglutide (Trulicity) | Semaglutide (Ozempic/Wegovy) |
|---|---|---|
| Manufacturer | Eli Lilly | Novo Nordisk |
| FDA Approval | September 2014 | December 2017 (Ozempic) |
| Approved For | Type 2 diabetes only | Diabetes + weight loss (Wegovy) |
| Formulations | Injection only | Injection + oral tablet (Rybelsus) |
| Frequency | Once weekly | Once weekly (injection) or daily (oral) |
| HbA1c Reduction | 1.1-1.4% | 1.5-1.8% |
| Average Weight Loss | 5-7 lbs | 10-14 lbs (Ozempic) / 35 lbs (Wegovy) |
| Half-Life | 120 hours (5 days) | 168 hours (7 days) |
| Monthly Cost | $900-$1,000 | $936-$1,349 |
What Is Dulaglutide (Trulicity)?
Dulaglutide is a GLP-1 receptor agonist manufactured by Eli Lilly and sold under the brand name Trulicity. The FDA approved it in September 2014 for treating type 2 diabetes in adults.
Trulicity works by mimicking the glucagon-like peptide-1 (GLP-1) hormone that your body naturally produces after eating. This helps stimulate insulin secretion, suppress glucagon release, and slow gastric emptying.
FDA-Approved Uses for Dulaglutide
- Type 2 diabetes mellitus: As an adjunct to diet and exercise to improve glycemic control
- Cardiovascular risk reduction: In adults with type 2 diabetes and established cardiovascular disease
Important: Dulaglutide is NOT FDA-approved for weight loss. Unlike semaglutide (which has Wegovy), there is no weight-loss-specific formulation of dulaglutide.
Trulicity comes as a single-dose prefilled pen for once-weekly subcutaneous injection. The starting dose is typically 0.75 mg, with options to increase to 1.5 mg, 3.0 mg, or a maximum of 4.5 mg based on your response.
What Is Semaglutide (Ozempic, Wegovy, Rybelsus)?
Semaglutide is a GLP-1 receptor agonist manufactured by Novo Nordisk, available under multiple brand names for different indications. It has 94% structural similarity to natural human GLP-1, which may contribute to its enhanced efficacy.
Semaglutide Brand Names and Formulations
- Ozempic: Injectable for type 2 diabetes (FDA approved December 2017)
- Wegovy: Injectable for chronic weight management (FDA approved June 2021)
- Rybelsus: Oral tablet for type 2 diabetes (FDA approved September 2019)
The key advantage of semaglutide is its versatility. You can get it as a once-weekly injection or a once-daily oral tablet, and it’s the only GLP-1 in this comparison with FDA approval specifically for weight loss.
FDA-Approved Uses for Semaglutide
- Type 2 diabetes: Ozempic and Rybelsus for improved glycemic control
- Chronic weight management: Wegovy for adults with obesity (BMI 30+) or overweight (BMI 27+) with weight-related conditions
- Cardiovascular risk reduction: In adults with type 2 diabetes and heart disease
- Pediatric weight management: Wegovy is approved for ages 12+ for weight loss
How Do Dulaglutide and Semaglutide Work?
Both dulaglutide and semaglutide are GLP-1 receptor agonists, meaning they work by activating the same receptors in your body. However, there are subtle differences in how they achieve their effects.
The GLP-1 Mechanism Explained
When you eat, your gut releases GLP-1 hormone. This hormone triggers several responses that help manage blood sugar and appetite:
- Stimulates insulin release: Signals pancreatic beta cells to produce more insulin when blood sugar rises
- Suppresses glucagon: Reduces the liver’s glucose production
- Slows gastric emptying: Food moves through your stomach more slowly, keeping you fuller longer
- Reduces appetite: Acts on brain regions that control hunger and satiety
Key Differences in Mechanism
While both medications work on GLP-1 receptors, semaglutide has a longer half-life (168 hours vs 120 hours) and higher binding affinity. According to research published in JAMA Network Open, semaglutide has the highest binding affinity among GLP-1 agonists, which may explain its superior efficacy in clinical trials.
Efficacy Comparison: SUSTAIN 7 Trial Results
The most important head-to-head comparison comes from the SUSTAIN 7 clinical trial, published in The Lancet Diabetes & Endocrinology in 2018. This study directly compared semaglutide and dulaglutide at comparable doses.
SUSTAIN 7 Trial Overview
- Study design: Randomized, open-label, phase 3b trial
- Participants: 1,201 adults with type 2 diabetes
- Duration: 40 weeks
- Locations: 194 hospitals across 16 countries
HbA1c Reduction Results
| Medication | Dose | HbA1c Reduction |
|---|---|---|
| Semaglutide | 0.5 mg | -1.5% |
| Semaglutide | 1.0 mg | -1.8% |
| Dulaglutide | 0.75 mg | -1.1% |
| Dulaglutide | 1.5 mg | -1.4% |
The difference was statistically significant (p=0.002), demonstrating that semaglutide provides superior glycemic control at both low and high doses compared to dulaglutide.
What This Means: Based on clinical trials, patients on semaglutide may achieve better blood sugar control, potentially reaching target HbA1c levels more effectively than those on dulaglutide.
Weight Loss Comparison: Which Works Better?
Semaglutide is significantly more effective for weight loss than dulaglutide. This is one of the clearest differences between these two medications, and it’s backed by robust clinical data.
SUSTAIN 7 Weight Loss Results
| Medication | Dose | Weight Loss (kg) | Weight Loss (lbs) |
|---|---|---|---|
| Semaglutide | 0.5 mg | -4.6 kg | ~10 lbs |
| Semaglutide | 1.0 mg | -6.5 kg | ~14 lbs |
| Dulaglutide | 0.75 mg | -2.3 kg | ~5 lbs |
| Dulaglutide | 1.5 mg | -3.0 kg | ~7 lbs |
The data shows semaglutide produces approximately double the weight loss of dulaglutide over 40 weeks. At higher doses (Wegovy 2.4 mg), weight loss can reach up to 15% of body weight, or an average of 35 pounds.
Why Semaglutide Wins for Weight Loss?
Several factors contribute to semaglutide’s superior weight loss results:
- Longer half-life: 168 hours versus 120 hours means more consistent appetite suppression
- Higher GLP-1 receptor binding: Stronger receptor activation leads to greater appetite reduction
- FDA approval for weight loss: Wegovy is dosed specifically for weight management (up to 2.4 mg)
Pro Tip: If weight loss is your primary goal, semaglutide (Wegovy) is the clear choice. It’s the only one of these medications FDA-approved specifically for chronic weight management.
Side Effects: Dulaglutide vs Semaglutide
Both medications share similar side effect profiles because they work on the same receptors. Gastrointestinal issues are the most common side effects for both drugs.
Common Side Effects Comparison
| Side Effect | Dulaglutide | Semaglutide |
|---|---|---|
| Nausea | 8-29% | Up to 20% |
| Diarrhea | Up to 13.7% | Common |
| Vomiting | Up to 11.5% | Common |
| Abdominal pain | Common | Common |
| Constipation | Common | Common |
| Fatigue | Common | Common |
Based on user reports and clinical data, individual tolerance varies significantly. Some patients tolerate one medication better than the other, which is why doctors sometimes recommend switching if side effects are intolerable.
Serious Warnings (Both Medications)
Both dulaglutide and semaglutide carry a boxed warning about thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Other serious side effects include:
- Pancreatitis: Severe abdominal pain may indicate inflammation of the pancreas
- Acute kidney injury: Particularly in patients with dehydration from GI side effects
- Hypoglycemia: Especially when combined with insulin or sulfonylureas
- Severe allergic reactions: Rare but possible
Semaglutide has an additional warning about diabetic retinopathy complications and monitoring for suicidal ideation in some patients.
Contraindications
Neither medication should be used if you have:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to the medication
- Type 1 diabetes
- Diabetic ketoacidosis
Dosage and Administration Comparison
Both medications are administered as once-weekly subcutaneous injections. However, their titration schedules and maximum doses differ.
Dulaglutide Dosing Schedule
| Phase | Dose | Duration |
|---|---|---|
| Starting dose | 0.75 mg | At least 4 weeks |
| Titration 1 | 1.5 mg | At least 4 weeks |
| Titration 2 | 3.0 mg | At least 4 weeks |
| Maximum dose | 4.5 mg | Maintenance |
Semaglutide (Ozempic) Dosing Schedule
| Phase | Dose | Duration |
|---|---|---|
| Initiation | 0.25 mg | 4 weeks |
| Titration 1 | 0.5 mg | At least 4 weeks |
| Titration 2 | 1.0 mg | At least 4 weeks |
| Maximum dose | 2.0 mg | Maintenance |
For weight loss with Wegovy, the titration extends to 2.4 mg over 16-20 weeks.
Key Dosing Differences
- Starting dose purpose: Semaglutide’s 0.25 mg is for tolerability only; dulaglutide’s 0.75 mg is therapeutic
- Oral option: Rybelsus (semaglutide) is available as a daily oral tablet (3 mg, 7 mg, 14 mg)
- Injection device: Dulaglutide uses single-dose pens; semaglutide uses multi-dose pens
Cost Comparison: Trulicity vs Ozempic Pricing
Both medications are expensive without insurance, with similar price points. However, insurance coverage and available savings programs can significantly affect your out-of-pocket costs.
Monthly Cost Without Insurance
| Medication | Monthly Cost (Cash Pay) |
|---|---|
| Trulicity (dulaglutide) | $900-$1,000 |
| Ozempic (semaglutide) | $936-$1,349 |
| Wegovy (semaglutide) | $1,349+ |
| Rybelsus (semaglutide oral) | $850-$1,000 |
Savings Programs Available
Both manufacturers offer savings programs:
- Trulicity: Eli Lilly offers savings cards for eligible patients, providing up to $150 savings per fill
- Ozempic: Novo Nordisk offers similar savings programs, up to $150 per prescription
- Patient Assistance: Both companies have programs for uninsured or underinsured patients
Insurance Coverage Considerations
Insurance coverage varies significantly based on your plan and intended use:
- For diabetes: Both medications typically covered by commercial insurance with prior authorization
- For weight loss: Only about 1% of ACA marketplace plans cover Wegovy for obesity
- Prior authorization: Often required for both medications; may need to try metformin first
Time Saver: Contact your insurance company before starting treatment to understand coverage requirements and potential out-of-pocket costs.
Telehealth Options for 2026
If you’re looking for accessible ways to get GLP-1 prescriptions, several telehealth providers offer consultations and medication delivery:
| # | Provider | Highlights | Price | |
|---|---|---|---|---|
| 01 | IvyRx |
|
From $197/mo | Learn More → |
| 02 | Ro Body |
|
From $145/mo | Learn More → |
| 03 | Hims/Hers |
|
From $199/mo | Learn More → |
We may earn a commission at no extra cost to you.
Disclaimer: Compounded medications are not FDA-approved and may not be available in all states.
Which Should You Choose?
Based on clinical evidence and real-world factors, here’s my recommendation framework:
Choose Semaglutide (Ozempic/Wegovy) If:
- Weight loss is a primary goal
- You want maximum HbA1c reduction
- You prefer an oral medication option (Rybelsus)
- Your insurance covers it at a reasonable cost
- You don’t mind potential supply shortages
Choose Dulaglutide (Trulicity) If:
- Your insurance covers Trulicity but not Ozempic
- Semaglutide is unavailable due to shortages
- You experience intolerable side effects on semaglutide
- Blood sugar control is your primary concern (weight loss secondary)
- You want a medication that may be easier to access
The Bottom Line
If clinical effectiveness is your top priority, semaglutide is the winner. However, the “best” medication is the one you can actually get, afford, and tolerate long-term.
I recommend discussing both options with your healthcare provider, considering your insurance coverage, and being prepared to try alternatives if your first choice isn’t available or tolerable.
Frequently Asked Questions
Which is better for weight loss, semaglutide or dulaglutide?
Semaglutide is better for weight loss. In the SUSTAIN 7 clinical trial, patients on semaglutide lost 10-14 pounds compared to 5-7 pounds on dulaglutide over 40 weeks. Additionally, semaglutide (as Wegovy) is FDA-approved for chronic weight management, while dulaglutide is not approved for weight loss.
What is better to take, Trulicity or Ozempic?
Ozempic (semaglutide) is generally more effective than Trulicity (dulaglutide) for lowering blood sugar and promoting weight loss based on clinical trial data. However, Trulicity may be better if you experience fewer side effects on it or have insurance that covers it more favorably. Your choice should consider health goals, tolerance, and cost.
Can you lose weight on dulaglutide?
Yes, you can lose weight on dulaglutide (Trulicity), though it is not FDA-approved for weight loss. Clinical studies show average weight loss of 5-7 lbs with dulaglutide, and some users report more at higher doses (3.0-4.5 mg). However, weight loss results are typically less than what semaglutide produces.
Can you switch from Trulicity to Ozempic?
Yes, you can switch from Trulicity to Ozempic under medical supervision. Your doctor will typically have you stop Trulicity and start Ozempic at the 0.25 mg initiation dose, then titrate up as tolerated. The transition is generally smooth since both are once-weekly GLP-1 medications.
What are the main differences between dulaglutide and semaglutide?
Key differences include: 1) Efficacy – semaglutide produces greater HbA1c reduction (1.5-1.8% vs 1.1-1.4%) and more weight loss, 2) Formulations – semaglutide is available as injection and oral tablet while dulaglutide is injection only, 3) FDA approvals – only semaglutide is approved for weight loss (Wegovy), 4) Half-life – semaglutide 168 hours vs dulaglutide 120 hours.
What is the new drug to replace Trulicity?
Several GLP-1 medications can serve as alternatives to Trulicity: semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), and liraglutide (Victoza, Saxenda). Tirzepatide is the newest option, working on both GLP-1 and GIP receptors for potentially greater efficacy. However, these are not direct replacements – each has different dosing, approvals, and costs.
Final Verdict: Dulaglutide vs Semaglutide
After analyzing the clinical trial data, real-world evidence, and practical considerations, semaglutide emerges as the more effective option for most patients seeking blood sugar control and weight loss.
The SUSTAIN 7 trial clearly demonstrated semaglutide’s superiority at both low and high doses. For weight loss specifically, semaglutide produces approximately double the results of dulaglutide.
However, dulaglutide remains a valuable option for patients who cannot access semaglutide due to shortages, insurance limitations, or side effect intolerance. Both medications offer significant benefits for managing type 2 diabetes and reducing cardiovascular risk.
Whichever medication you choose, remember that success depends on combining pharmacotherapy with lifestyle changes including diet and exercise. Work closely with your healthcare provider to determine the best approach for your individual situation.
This review is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any weight-loss or diabetes medication.